Difficulty: Medium
Average Score: 69%
Practice
The correct method for determining the vastus lateralis site for I.M. injection is to:
Correct answer
D
Rationale
The correct answer is D because the vastus lateralis muscle is located in the anterior thigh, and the described method ensures proper localization for a safe intramuscular (I.M.) injection. The vastus lateralis is part of the quadriceps muscle group and is a common site for I.M. injections, particularly in infants and adults when other sites are contraindicated. To locate it, the clinician divides the thigh between the greater trochanter (the bony prominence at the top of the femur) and the lateral femoral condyle (the bony protrusion on the outer side of the knee) into thirds. The middle third on the anterior aspect of the thigh is the correct injection site, as it avoids major nerves and blood vessels while ensuring the medication is delivered into the muscle mass. This method is widely accepted in clinical practice and supported by anatomical studies.
Choice A is incorrect because it describes the dorsogluteal site (upper outer quadrant of the buttock), which is not the vastus lateralis. The dorsogluteal site is associated with the gluteus maximus muscle and carries a higher risk of injuring the sciatic nerve or superior gluteal artery if not properly located. While it is a valid I.M. injection site, it is not the correct answer for targeting the vastus lateralis.
Choice B is incorrect because it refers to the deltoid muscle site, located on the lateral aspect of the arm. The deltoid is another common I.M. injection site, particularly for vaccines, but it is not the vastus lateralis. The described landmark (acromion process) is specific to the deltoid and irrelevant to locating the vastus lateralis in the thigh.
Choice C is incorrect because it describes an area on the abdomen (anterior to the umbilicus), which is not used for I.M. injections. The abdominal area is typically associated with subcutaneous injections (e.g., insulin) due to the presence of adipose tissue, not muscle mass. There is no valid anatomical basis for administering an I.M. injection in this location, making it entirely unrelated to the vastus lateralis.
The correct method (D) ensures accurate placement in the vastus lateralis, minimizing complications such as nerve injury, injection into subcutaneous tissue, or accidental entry into blood vessels. The other choices either describe alternative injection sites or irrelevant anatomical locations, demonstrating a misunderstanding of the vastus lateralis's position and function. Proper identification of anatomical landmarks is critical for safe and effective I.M. injections, and the vastus lateralis is particularly advantageous due to its accessibility and reduced risk of complications compared to other sites.
Choice A is incorrect because it describes the dorsogluteal site (upper outer quadrant of the buttock), which is not the vastus lateralis. The dorsogluteal site is associated with the gluteus maximus muscle and carries a higher risk of injuring the sciatic nerve or superior gluteal artery if not properly located. While it is a valid I.M. injection site, it is not the correct answer for targeting the vastus lateralis.
Choice B is incorrect because it refers to the deltoid muscle site, located on the lateral aspect of the arm. The deltoid is another common I.M. injection site, particularly for vaccines, but it is not the vastus lateralis. The described landmark (acromion process) is specific to the deltoid and irrelevant to locating the vastus lateralis in the thigh.
Choice C is incorrect because it describes an area on the abdomen (anterior to the umbilicus), which is not used for I.M. injections. The abdominal area is typically associated with subcutaneous injections (e.g., insulin) due to the presence of adipose tissue, not muscle mass. There is no valid anatomical basis for administering an I.M. injection in this location, making it entirely unrelated to the vastus lateralis.
The correct method (D) ensures accurate placement in the vastus lateralis, minimizing complications such as nerve injury, injection into subcutaneous tissue, or accidental entry into blood vessels. The other choices either describe alternative injection sites or irrelevant anatomical locations, demonstrating a misunderstanding of the vastus lateralis's position and function. Proper identification of anatomical landmarks is critical for safe and effective I.M. injections, and the vastus lateralis is particularly advantageous due to its accessibility and reduced risk of complications compared to other sites.